Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny probe could give doctors a window into infant brains

NCT ID NCT06646250

Recruiting now Knowledge-focused Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, lightweight ultrasound device called NeoDoppler that can be gently placed on a newborn's soft spot (fontanelle) to continuously measure blood flow in the brain. Researchers will enroll 180 preterm and full-term infants, including those with conditions like sepsis, stroke, or heart defects. The goal is to see if the device provides reliable, high-quality measurements that could help doctors monitor brain health in real time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
NeoDoppler device
What this could lead to
If successful, this could provide doctors with a better, non-invasive way to continuously monitor brain blood flow in fragile newborns, potentially improving care for conditions like stroke or sepsis.
What could go wrong
This is an early-stage device study focused on measurement quality, not treatment outcomes. The device may not prove reliable enough for routine clinical use, and results may not apply to all infant populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASPHYXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Asphyxia congenital heart disease infectious disease infectious disease with sepsis meningitis patent ductus arteriosus perinatal asphyxia Premature Birth pulmonary hypertension Sepsis stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASPHYXIA CONGENITAL HEART DISEASE PATENT DUCTUS ARTERIOSUS PRETERM PULMONARY HYPERTENSION SEPSIS STROKE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Children's clinic, St. Olavs University Hospital

    RECRUITING

    Trondheim, 7030, Norway

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.